Jagan Muppidi

2.2k total citations
33 papers, 1.3k citations indexed

About

Jagan Muppidi is a scholar working on Immunology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Jagan Muppidi has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Pathology and Forensic Medicine and 13 papers in Genetics. Recurrent topics in Jagan Muppidi's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Immune Cell Function and Interaction (12 papers). Jagan Muppidi is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Immune Cell Function and Interaction (12 papers). Jagan Muppidi collaborates with scholars based in United States, United Kingdom and Japan. Jagan Muppidi's co-authors include Richard M. Siegel, Jürg Tschopp, Adrian A. Lobito, Jason G. Cyster, Erick Lu, Melissa Porter, Hirsh D. Komarow, Daniel L. Kastner, Fiona C. Kimberley and Keith M. Hull and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Jagan Muppidi

32 papers receiving 1.3k citations

Peers

Jagan Muppidi
Taylor B. Guo China
Makiko Kawaguchi Japan
Nigel Sharfe Canada
Luke W. Thomas United Kingdom
Xinghao Wang United States
Rika Ouchida Japan
David Liberg Sweden
Amnon Altman United States
Jinbiao Chen Australia
Kathrin Weber Germany
Taylor B. Guo China
Jagan Muppidi
Citations per year, relative to Jagan Muppidi Jagan Muppidi (= 1×) peers Taylor B. Guo

Countries citing papers authored by Jagan Muppidi

Since Specialization
Citations

This map shows the geographic impact of Jagan Muppidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagan Muppidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagan Muppidi more than expected).

Fields of papers citing papers by Jagan Muppidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jagan Muppidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagan Muppidi. The network helps show where Jagan Muppidi may publish in the future.

Co-authorship network of co-authors of Jagan Muppidi

This figure shows the co-authorship network connecting the top 25 collaborators of Jagan Muppidi. A scholar is included among the top collaborators of Jagan Muppidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagan Muppidi. Jagan Muppidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melani, Christopher, Max J. Gordon, Stefania Pittaluga, et al.. (2024). Abstract PO-008: Phase I/II study of VIP152 (enitociclib), venetoclax, and prednisone (VVIP) in relapsed/refractory (R/R) lymphoid malignancies. Blood Cancer Discovery. 5(3_Supplement). PO–8.
2.
An, Jinping, et al.. (2024). Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity. The Journal of Experimental Medicine. 221(11). 2 indexed citations
3.
Hang, Nguyen Thi Thu, Huifang Li, Yandan Yang, et al.. (2024). Gα13 restricts nutrient driven proliferation in mucosal germinal centers. Nature Immunology. 25(9). 1718–1730. 2 indexed citations
4.
Dalela, D., Christopher Melani, Stefania Pittaluga, et al.. (2024). A Pilot Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (VIPOR) for Diffuse Large B-Cell Lymphoma Involving the Central Nervous System. Blood. 144(Supplement 1). 1724–1724. 1 indexed citations
5.
Raso, Fiona, Gregory M. Barton, Christian T. Mayer, et al.. (2023). Antigen receptor signaling and cell death resistance controls intestinal humoral response zonation. Immunity. 56(10). 2373–2387.e8. 9 indexed citations
6.
Dalela, D., Stefania Pittaluga, Jagan Muppidi, et al.. (2023). IBCL-297 Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL). Clinical Lymphoma Myeloma & Leukemia. 23. S451–S451. 1 indexed citations
7.
8.
Nguyen, Hang Thi Thu, Bonnie Huang, Takaharu Okada, et al.. (2022). Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma. Blood. 140(10). 1119–1131. 8 indexed citations
9.
Pittaluga, Stefania, Jagan Muppidi, James D. Phelan, et al.. (2021). Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas. Blood. 138(Supplement 1). 4504–4504. 8 indexed citations
10.
11.
Melani, Christopher, Michail S. Lionakis, Stefania Pittaluga, et al.. (2020). Preliminary Results of a Response-Adapted Study of Ibrutinib and Isavuconazole with Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma. Blood. 136(Supplement 1). 24–25. 5 indexed citations
12.
Lu, Erick, et al.. (2019). S-Geranylgeranyl-l-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature. 567(7747). 244–248. 56 indexed citations
13.
Melani, Christopher, Stefania Pittaluga, Miloš D. Miljković, et al.. (2019). Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis. Blood. 134(Supplement_1). 2867–2867. 2 indexed citations
14.
Wu, Shuang, Timothy Evans, Jagan Muppidi, et al.. (2016). Clathrin light chains’ role in selective endocytosis influences antibody isotype switching. Proceedings of the National Academy of Sciences. 113(35). 9816–9821. 26 indexed citations
15.
Muppidi, Jagan, Erick Lu, & Jason G. Cyster. (2015). The G protein–coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination. The Journal of Experimental Medicine. 212(13). 2213–2222. 44 indexed citations
16.
Ramaswamy, Madhu, Céline Dumont, Anthony Cruz, et al.. (2007). Cutting Edge: Rac GTPases Sensitize Activated T Cells to Die via Fas. The Journal of Immunology. 179(10). 6384–6388. 34 indexed citations
17.
Muppidi, Jagan, Adrian A. Lobito, Madhu Ramaswamy, et al.. (2006). Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death and Differentiation. 13(10). 1641–1650. 48 indexed citations
18.
Muppidi, Jagan & Richard M. Siegel. (2004). Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nature Immunology. 5(2). 182–189. 172 indexed citations
19.
Muppidi, Jagan, Jürg Tschopp, & Richard M. Siegel. (2004). Life And Death Decisions. Immunity. 21(4). 461–465. 290 indexed citations
20.
Siegel, Richard M., et al.. (2003). Death Receptor Signaling and Autoimmunity. Immunologic Research. 27(2-3). 499–512. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taylor B. Guo Breakdown of academic impact, for papers by Makiko Kawaguchi Breakdown of academic impact, for papers by Nigel Sharfe Breakdown of academic impact, for papers by Luke W. Thomas Breakdown of academic impact, for papers by Xinghao Wang Breakdown of academic impact, for papers by Rika Ouchida Breakdown of academic impact, for papers by David Liberg Breakdown of academic impact, for papers by Amnon Altman Breakdown of academic impact, for papers by Jinbiao Chen Breakdown of academic impact, for papers by Kathrin Weber
Rankless by CCL
2026